Journal profile · Medicine-Oncology
Cancer Informatics
ISSN 1176-9351 · Libertas Academica · United Kingdom
Cancer Informatics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.1 (journal website); fully open access; APC about USD 2,650; median 130 days to acceptance (69 articles, last 24 months); 26 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cancer Informatics is published by Libertas Academica and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gene expression and cancer classification, Bioinformatics and Genomic Networks and Cancer Genomics and Diagnostics, together about 39.4% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Cancer Informatics is an international, peer reviewed, open access journal that publishes high quality bioinformatics analyses of molecular genetics and/or clinical data pertaining to human cancer risk, prevention, outcome, or treatment response. View full journal description This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief J.T. Efird VAPublisher website
Editorial board by country: 3 in mainland China (about 3%); most named United States 51, Italy 5, India 4, Germany 4, Mainland China 3 (88 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gene expression and cancer classificationBiochemistry, Genetics and Molecular Biology17.8%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology14.9%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology6.7%
- Ferroptosis and cancer prognosisMedicine4.8%
- Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology4.1%
- Computational Drug Discovery MethodsComputer Science3.6%
- AI in cancer detectionComputer Science3.5%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Mathematical & Computational Biology | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Mathematical & Computational Biology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.1Publisher website ·
- 5-year impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 0.6LetPub ·
- h-index
- 49OpenAlex ·
- i10-index
- 302OpenAlex ·
- 2-year mean citedness
- 1.52OpenAlex ·
- Self-citation rate
- 9.5%LetPub ·
- Share of gold OA articles
- 98.77%LetPub ·
Volume
- Articles per year
- 24LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 738 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 5 |
| 2025 | 26 | 26 | 47 |
| 2024 | 23 | 23 | 85 |
| 2023 | 36 | 36 | 301 |
| 2022 | 40 | 40 | 492 |
| 2021 | 19 | 19 | 314 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
130 daysMedian, submission to acceptance · P25–P75 107 days – 162 days
- Acceptance to online
- median 30 days (69 articles)
- Submission to online
- median 162 days
- Sample
- 69 articles with submission and acceptance dates (75 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,650 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,650 | — | — | |
| LetPub | USD 2,650 | Yes | — | |
| Publisher website | USD 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 300 words
- Reference style
- AMA
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted6
- commentaryView our Special Collections currently accepting submissions. Manuscript types eligible for submission are described below. Original Research Original Research …Length not stated
- original paperView our Special Collections currently accepting submissions. Manuscript types eligible for submission are described below. Original Research Original Research …Length not stated
- original researchView our Special Collections currently accepting submissions. Manuscript types eligible for submission are described below. Original Research Original Research …Length not stated
- original research articleView our Special Collections currently accepting submissions. Manuscript types eligible for submission are described below. Original Research Original Research …Length not stated
- research articleView our Special Collections currently accepting submissions. Manuscript types eligible for submission are described below. Original Research Original Research …Length not stated
- reviewView our Special Collections currently accepting submissions. Manuscript types eligible for submission are described below. Original Research Original Research …Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Cancer Informatics is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder…
Source ↗Publisher website ·- Peer review Peer review policy
The following summary describes the peer review process for this journal: Identity transparency:Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk reject…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Libertas Academica
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1176-9351
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cancer Informatics
What CAS zone is Cancer Informatics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Informatics is in Zone 4 of Medicine, and in Zone 4 of the minor category Mathematical & Computational Biology / Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer Informatics?
The journal's website gives an impact factor of 2.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.9, h-index 49.
How long does peer review take at Cancer Informatics?
Based on the dates recorded on 69 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 130 days (interquartile range 107–162 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cancer Informatics?
According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: AMA; Templates: Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cancer Informatics based?
Of the 88 board members whose country the journal's board page names, 3 (about 3%) are in mainland China; the countries named most often are United States (51), Italy (5) and India (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Cancer Informatics?
According to LetPub and DOAJ records, Cancer Informatics is indexed in ESCI, Scopus and DOAJ.
Is Cancer Informatics open access, and what is the APC?
Cancer Informatics is a fully open-access journal. APC about USD 2,650.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .